4YRSBeijing Diagreat Biotechnologies Co., Ltd.

Panoramica aziendale

Album aziendale3

Informazioni di base
Beijing Diagreat Biotech Co., LtdHeadquartered in Beijing since 2013, Diagreat is a high-tech enterprise specializing in developing, manufacturing and distributing of IVD (In Vitro Diagnosis) Products. At present, We have more than 100 employees including more than 80 R&D staff (5 PHD staff and 8 master staff). Our current factory covers about 10,000 square meters. And we have two subsidiaries, Beijing Deoping Biotechnology Co., Ltd. and Hunan Desigm Biotechnology Co., Ltd.Continuous innovation: On the strong basis of professional R&D team with rich experience and expertise in IVD area, we have established strategic collaborations with local and foreign Universities to set up joint facilities such as R&D Labs and teaching workshops. We apply more than ten invention patents every year, and until now more than 60 in vitro diagnostic registered products have been developed.Core technology: Diagreat has a complete industrial chain technology platform. It covers all key aspects of R&D and production of IVD reagents and instruments. The IVD reagents include gene protein and monoclonal antibody technology platforms, nanoparticle platform, time-resolved immunofluorescence technology platform. The company's technology core highlights are fully automatic chemiluminescence instrument and reagent platform.Excellence Products: Diagreat has biochemical series products such as POCT fluorescence and chemiluminescence products, as well as antibody raw material series, OEM series products and many other product lines, which can meet different stages and different market segments in wide range.The products from Diagreat have covered most of the major hospitals, research institutes and other medical service units in China. While enjoying high reputation in domestic market, our business is also expanded to more than 50 overseas regions including France, Spain, Bulgaria, Singapore, Pakistan, Vietnam, Middle East, Latin-America, etc. Along with product progress and business growth, Diagreat sincerely hopes to work with customers all over the world on product distribution and OEM/ODM. We believe that our customers and partners' best interest will be assured through our cooperation.
0.0/5
0 Reviews
  • Le operazioni di
    -
  • Tempo di risposta
    ≤18h
  • Tasso di risposta
    35.71%
Tipo di attività
Produttore
Paese / Regione
Beijing, China
Prodotti principaliTotale dipendenti
201 - 300 People
Entrate totali annue
US$5 Million - US$10 Million
Anno di fondazione
2013
Certificazioni(1)Certificazioni di prodotto(1)
Brevetti(31)
A test strip for detecting paclitaxel drugs and its preparation method and application, 250HD3 detection reagent, kit and detection method thereof, Novel coronavirus dominant epitope fusion protein, diagnostic reagent and application, A pretreatment agent for cyclosporine whole blood samples and its application method, Docetaxel derivative, docetaxel artificial antigen, hybridoma cell line, docetaxel monoclonal antibody and application, A mixing device for genetic engineering experiments, Invention Patent Certificate_An Immunological Detection Method of Risperidone and _ or 9-Hydroxyrisperidone, A convenient and practical colloidal gold kit, A method for measuring 25-hydroxyvitamin D content, Fluorescence Immunochromatography, A test strip, kit and test strip preparation method for detecting mycophenolic acid, A kit for specific detection of creatine kinase isoenzymes, Automatic Drug Concentration Analyzer, A kind of assay kit for detecting myoglobin, A kind of risperidone and 9-hydroxy risperidone hapten, antigen and antibody and application thereof, Antigen emulsification device, A quantitatively identifiable blood filter sampling and dissolution device, Recombinant protein, test strip, preparation method and application of a double-antigen sandwich method for detecting 2019 novel coronavirus antibody, A detection reagent and detection kit for detecting risperidone and or 9-hydroxyrisperidone, Hapten derivatives of oxcarbazepine metabolites, artificial antigens and monoclonal antibodies and their applications, hybridoma cell lines, Fully automatic chemiluminescence immunoassay analyzer, Detachable combined blood sample test tube storage box for medical use, A kind of tacrolimus whole blood sample pretreatment liquid and its use method and application, Single serving chemiluminescence immunoassay analyzer, A kind of immunological detection method of imatinib and or N-desmethyl imatinib, A kit for detecting immunoglobulin G in urine, A laboratory centrifuge, Fully automatic chemiluminescence immunoassay analyzer, Isoniazid hapten derivative, isoniazid artificial antigen, hybridoma cell line, isoniazid monoclonal antibody and application, A vibration response device for medical testing, A detection reagent and detection kit for detecting imatinib and _ or N-desmethylimatinib
Marchi commerciali
-
Mercati principali

Capacità di prodotto

Informazioni di fabbrica

Dimensione della fabbrica
5,000-10,000 square meters
Posizione della fabbrica
Floors 1-3, Building 19, Yard 2, Huanke Middle Road, Beijing Economic and Technological Development Zone (tongzhou), Beijing City, China
N. di linee di produzione
Above 10
Contratto d'opera
OEM Service Offered, Design Service Offered, Buyer Label Offered
Valore della produzione annua
US$5 Million - US$10 Million